Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Activating mutations in Kirsten rat sarcoma viral oncogene homologue (KRAS), in particular, a point mutation leading to a glycine-to-cysteine substitution at codon 12 (G12C), are among the most frequent genomic alterations in non-small cell lung cancer (NSCLC). Several agents targeting KRAS G12C hav...
| Publicado en: | Current Oncology Vol. 30; no. 7; pp. 6473 - 6497 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |